Jun 5 2007
AION Diagnostics Inc, a nano-diagnostics company commercializing medical imaging agents, announced today the appointment of William E. Gannon Jr., M.D., M.B.A., expert in clinical and regulatory affairs, to its Scientific Advisory Board.
Dr Gannon is founder and Chief Medical Officer of Apthera Inc., a company commercializing a peptide-based immunotherapy for the treatment of early-stage Her2-positive breast cancer. Dr. Gannon is an expert in the development, commercialization, marketing and management of health-care products and medical devices. With extensive senior management level experience at two of the worlds largest Regulatory Contract Research Organizations; Quintiles and Pharmaceutical Product Development Inc, Dr. Gannon also holds expertise in the management of regulatory global submissions. This includes experience with FDA processes, European (ISO 9000), Canadian and Japanese regulatory environments as well as IBC AHA and JCAHO affairs. Dr. Gannon is an experienced biopharmaceutical executive, most recently with oncology focused company, Celsion Corporation.
'Dr. Gannon's regulatory and clinical expertise will further support and accelerate commercialization of AION's products,' reported Dr. Anna Kluczewska, President and CEO of AION.